Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
We've already indexed 153 COAs attributed to your lab across 7 peptide vendors. Claim this profile and every record links back to you — the canonical source. Free forever.
Auto-generated from public COAs across the corpus. Based in US.
bioregen.comAlso seen on COAs as: bioregen labs
Tracking since .
Every reported purity value from BioRegen, bucketed every 0.5 percentage points. The shape of the distribution is the safety signal — narrow clustering across many COAs is the rubber-stamping fingerprint we flag.
A healthy distribution spreads across multiple bins. A single tall spike (variance under 0.5pp across 10+ COAs) trips the SUSPICIOUSLY_NARROW_VARIANCE flag — see methodology.
What fraction of this lab's COAs report each test type. Real third-party labs typically run a consistent panel; sparse coverage on safety tests (endotoxin, sterility) is a common signal of HPLC-only purity work. Endotoxin is measured against injectable COAs only — raw powders and orals aren't expected to carry it.
Cross-verification events on this lab's COAs. Lab-confirmed and mirror-upload counts feed the +10 verification-engagement bonus in the credibility score; disputes deduct points.
| Vendor | Peptide | Lot | Purity | Endo | Tested | |
|---|---|---|---|---|---|---|
| BioLongevity Labs | GHK-Cu | 11-3-46057 | 99.81% | — | 2026-02-13 | View |
| BioLongevity Labs | Cartalax | 35-3-46057 | 99.63% | — | 2026-02-13 | View |
| BioLongevity Labs | Vesugen | 46-3-46057 | 99.76% | — | 2026-02-13 | View |
| BioLongevity Labs |
| Kisspeptin-10 |
| 14-3-46057 |
| 99.68% |
| — |
| 2026-02-12 |
| View |
| Forge Performance Co. | BPC-157 | — | 99.53% | — | 2026-02-09 | View |
| BioLongevity Labs | Testagen | 43-3-46035 | 99.83% | — | 2026-02-06 | View |
| BioLongevity Labs | Livagen | 38-3-46035 | 99.63% | — | 2026-02-05 | View |
| BioLongevity Labs | DSIP | 8-3-46035 | 99.82% | — | 2026-02-05 | View |
| BioLongevity Labs | Epithalon | 9-3-46035 | 99.73% | — | 2026-02-05 | View |
| BioLongevity Labs | VIP | 31-3-46041 | 99.72% | — | 2026-02-04 | View |
| BioLongevity Labs | Thymogen | 44-3-46031 | 99.74% | — | 2026-02-04 | View |
| BioLongevity Labs | BPC-157 | 4-3-46031 | 99.60% | — | 2026-02-04 | View |
| BioLongevity Labs | Thymoген | 44-3-46035 | 99.83% | — | 2026-02-04 | View |
| BioLongevity Labs | ARA-290 | 2-3-46035 | 99.74% | — | 2026-01-30 | View |
| BioLongevity Labs | Tesamorelin | 28-3-46031 | 99.54% | — | 2026-01-30 | View |
| BioLongevity Labs | Ipamorelin | 13-3-46031 | 99.53% | ✓ | 2026-01-29 | View |
| BioLongevity Labs | Ipamorelin | 29-3-46035 | 99.54% | — | 2026-01-29 | View |
| BioLongevity Labs | Tesamorelin | 29-3-46035 | 99.92% | — | 2026-01-29 | View |
| Forge Performance Co. | TB-500 | — | 99.63% | — | 2026-01-28 | View |
| BioLongevity Labs | NAD+ | 21-3-46035 | 99.63% | — | 2026-01-28 | View |
| BioLongevity Labs | PT-141 | 25-3-46035 | 99.64% | — | 2026-01-27 | View |
| BioLongevity Labs | BPC-157/TB4/Cartalax Blend | 90-3-46041 | 99.61% | — | 2026-01-26 | View |
| BioLongevity Labs | BPC-157/TB4/Cartalax Blend | — | 99.72% | — | 2026-01-26 | View |
| BioLongevity Labs | BPC-157/TB4/Cartalax Blend | — | 99.54% | — | 2026-01-26 | View |
| BioLongevity Labs | BPC-157 | 90-3-46041 | 99.61% | — | 2026-01-26 | View |
| Peptide Partners | PT-141 | PT202512 | 99.89% | ✓ | 2026-01-12 | View |
| Forge Performance Co. | Tirzepatide | — | 99.82% | — | 2026-01-07 | View |
| Forge Performance Co. | Retatrutide | — | 99.62% | — | 2025-12-22 | View |
| Forge Performance Co. | Retatrutide | — | 99.87% | — | 2025-12-22 | View |
| Forge Performance Co. | Retatrutide | — | 99.87% | — | 2025-12-22 | View |
| Forge Performance Co. | Retatrutide | — | 99.62% | — | 2025-12-22 | View |
| Peptide Partners | MOTS-c | MC202512 | 99.89% | — | 2025-12-22 | View |
| Peptide Partners | GHK-Cu | GK202512 | 99.79% | — | 2025-12-19 | View |
| Real Peptides | TB-500 | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | Tirzepatide | — | 98.13% | — | 2025-12-15 | View |
| Real Peptides | TB 500 | — | 99.67% | — | 2025-12-15 | View |
| Real Peptides | Cartalax | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | Tesamorelin / Ipamorelin Blend | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | CJC-1295 no DAC | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | LL-37 | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | Epithalon | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | GHK-Cu | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | Semaglutide | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | PE-22-28 | — | — | ✓ | 2025-12-15 | View |
| Real Peptides | Sermorelin | — | 99.75% | — | 2025-12-11 | View |
| Real Peptides | Cartalax | — | 99.91% | — | 2025-12-11 | View |
| Real Peptides | GHK-Cu | — | 99.80% | — | 2025-12-11 | View |
| Real Peptides | DSIP | — | 99.87% | — | 2025-12-11 | View |
| Real Peptides | CJC 1295 No DAC | — | 99.74% | — | 2025-12-11 | View |
| Real Peptides | LL-37 | — | 99.83% | — | 2025-12-11 | View |
Disclosed Labs